PEP-Therapy Competitors and Similar CompaniesClear all

PEP-Therapy's competitors and similar companies include Aeglea, Harpoon Therapeutics, ISA Pharmaceuticals and Medigen.

	PEP-Therapy PEP-Therapy is a medical biotechnology company, that develops peptides as targeted therapies for severe diseases, with an initial focus on cancer.	Aeglea Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics.	Harpoon Therapeutics Harpoon Therapeutics is a preclinical stage biotechnology company.	ISA Pharmaceuticals ISA Pharmaceuticals is an immunotherapy company.	Medigen Medigen is a vaccine company developing vaccines against emerging infectious diseases and chronic diseases including cancer.
Founding Date	Founding Date 2014	Founding Date 2013	Founding Date 2015	Founding Date 2004	Founding Date 2004
Type	Type Private	Type Public	Type Public	Type Private	Type Private
Tags	Tags Healthcare biotech drug development oncology	Tags Healthcare biotech drug development oncology	Tags Healthcare biotech drug development oncology	Tags Healthcare biotech drug development oncology	Tags Healthcare biotech drug development oncology
Locations	Locations Paris, FR HQ Évry, FR	Locations Austin, US HQ	Locations South San Francisco, US HQ Louisville, US South San Francisco, US	Locations HQ	Locations Lindenwold, US HQ
Employees	Employees 14	Employees 65117% increase	Employees 45	Employees 517% decrease	Employees 39
Valuation ($)	Valuation ($) N/A	Valuation ($) 48.6 m	Valuation ($) 492.3 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Net income	Net income N/A	Net income ($155.2m) (FY, 2025)	Net income ($67.7m) (FY, 2022)	Net income N/A	Net income N/A
Funding
Latest funding round	Latest funding round $ 3m (almost 5 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 30.8m (almost 5 years ago)	Latest funding round N/A
Total funding raised	Total funding raised $ 3m	Total funding raised N/A	Total funding raised $ 130m	Total funding raised $ 41.2m	Total funding raised N/A